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Abstract
Introduction: Healthcare management is oriented toward single diseases, yet multimorbidity is nevertheless the rule and
there is a tendency for certain diseases to occur in clusters. This study sought to identify comorbidity patterns in patients
with chronic diseases, by reference to number of comorbidities, age and sex, in a population receiving medical care from
129 general practitioners in Spain, in 2007.
Methods: A cross-sectional study was conducted in a health-area setting of the Madrid Autonomous Region (Comunidad
Auto ´noma), covering a population of 198,670 individuals aged over 14 years. Multiple correspondences were analyzed to
identify the clustering patterns of the conditions targeted.
Results: Forty-two percent (95% confidence interval [CI]: 41.8–42.2) of the registered population had at least one chronic
condition. In all, 24.5% (95% CI: 24.3–24.6) of the population presented with multimorbidity.
In the correspondence analysis, 98.3% of the total information was accounted for by three dimensions. The following four,
age- and sex-related comorbidity patterns were identified: pattern B, showing a high comorbidity rate; pattern C, showing a
low comorbidity rate; and two patterns, A and D, showing intermediate comorbidity rates.
Conclusions: Four comorbidity patterns could be identified which grouped diseases as follows: one showing diseases with a
high comorbidity burden; one showing diseases with a low comorbidity burden; and two showing diseases with an
intermediate comorbidity burden.
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Introduction
Over the course of the past century, improvements in living
conditions and healthcare efficacy have led to an increase in the
prevalence of chronic diseases. Furthermore, the prolongation of
life expectancy means that the concurrence of more than one
disease in any given individual is becoming increasingly frequent
[1–5], a phenomenon defined as comorbidity or multimorbidity,
depending on whether one is considering an association of diseases
in relation to an index disease, or simply a relationship among
multiple diseases without any one disease being taken as the point
of reference.
Multimorbidity is present in one third of the adult population
and its prevalence increases with age, reaching a prevalence of
60% among individuals aged 55 to 74 years [6]. Moreover, the
existence of a tendency of some chronic diseases to form clusters
has also been demonstrated [7].
When patients visit the physician, they tend to seek medical
attention for more than one health problem. At each session,
general practitioners (GPs) deal with an average of over three
problems [8]. Individuals with multimorbidity register a higher
mortality rate [9], occasion higher healthcare costs, and have: a
higher risk of hospital admissions which, as ambulatory care
sensitive conditions (ACSC), would otherwise be preventable [5]; a
poorer perception of their physical and mental health; a poorer
quality of life [10]; and a diminished functional capacity [11]. This
is a challenge for GPs, who are tasked with treating patients rather
than specific diseases. The result is that the whole is greater than
the sum of the parts and [12], in view of its incidence and
socioeconomic impact, multimorbidity thus constitutes a challenge
to healthcare services in the 21
st century [13].
Research targets single diseases. Models of care for chronically
ill patients are directed toward the management of each disease
separately (disease management programs) and the clinical
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32141practice guidelines upon which such models are based also focus
on single diseases [14].
Research into multimorbidity, which began relatively recently,
is limited and under 3% of all published studies involve the
primary care setting [6]. These studies lack uniformity in the
definition of the concept of multimorbidity, type and number of
diseases or conditions studied, data-sources used, and methods
employed. This, together with the low number of studies, renders
inter-study comparison difficult, and an international agenda for
research in this field has thus been promoted [15] for the purpose
of gaining in-depth knowledge of the characteristics of multi-
morbidity and adapting the care model to this new reality.
Most available studies focus on ascertaining prevalence and its
distribution by age and sex [16]. Recently, some studies have been
published which analyze the formation of chronic disease clusters
[17,18] but more remains to be learned about the clustering of
chronic diseases and the risk factors that determine such
clustering.
Accordingly, this study sought to identify comorbidity patterns
in patients with chronic diseases, by reference to number of
comorbidities, age and sex, in a population receiving medical care
from 129 GPs in Spain, in 2007.
Methods
We conducted a study in a health area setting in the Madrid
Autonomous Region (Comunidad Auto ´noma), Spain, having a
catchment population of 887,134, representative of the Spanish
population in terms of age and sex.
Spain has a public healthcare system affording universal
coverage, and all citizens are required to register with a physician:
GPs provide care to the population over the age of 14 years, and
subjects under this age receive pediatric care.
The study was based on the electronic medical records (EMRs) of
198,670 individuals, corresponding to the population registered with
129 GPs who, by way of inclusion criteria, met the following two
EMR quality requirements: 1) they had kept notes on more than 64%
of all visits received (75
thpercentile); and, 2) they had recorded a mean
of over four care episodes per patient across the study period (2007).
Data collected on patients included their respective ages, sex and
all diagnoses for which they had visited the doctor in 2007. Patients
were classified using the Adjusted Clinical GroupsH (ACGH) Case-
Mix System, version 7 [19]. ACGs are mutually exclusive groups of
patients who make similar use of available resources over the course
of the year (iso-resource groups). This classification system also
generates categories termed ‘‘Expanded Diagnosis Clusters’’
(EDCs), which group patients on the basis of clinical criteria.
On the basis of pre-established criteria [20], the research team
made an initial selection of 40 chronic EDCs, of which, taking
prevalence and/or impact on health services into account, they
finally selected 26.
All statistical analyses were performed using the SAS/STAT
software package, and the graphs were designed with Stata 10.
Qualitative variables were described by means of frequency
distributions, along with their 95% confidence intervals where
appropriate; in the case of quantitative variables, means and
standard deviations were calculated. We calculated the prevalence
of multimorbidity (two or more chronic diseases) and its 95%
confidence interval and, taking each of the 26 chronic diseases as
the index disease, described the comorbidity pattern vis-a `-vis the
other chronic diseases and quantified the proportion of patients
corresponding to each of the six comorbidity levels.
Multiple correspondence analysis was used to obtain an overall
idea of the data and the interrelationships among the different
chronic diseases, taking age and sex into account. The method
affords a graphic technique that displays each category as a point
in a type of scatter plot. The positions of the category-points on
this map indicate similarity or association between categories.
Response-option points at the far end of the scatter plot show
levels of repulsion between categories.
The method used followed the following steps: first, each chronic
disease wasdichotomized into 2 modalities (presence, absence),with
eachmodalitythenbeingdeemed a separate variableinthe analysis.
Age was classified into 7 categories. Finally a total of 28 variables
with 61 different categories were included in the analysis. This
meant that all the cross-tabulationsof the 28 variables, includingthe
cross-tabulations of the variables with themselves, were completely
explained by 33 dimensions, i.e., the set of all the dimensions
constitutes 100% of the original information. The existence of an
association among the various categories allows for a reduction in
the number of dimensions needed to explain the data, with some
dimensions capturingmore information than others. Theamount of
information explained by each dimension is evaluated using
Benze ´cri inertia adjustment [21].
Second, several statistical parameters were calculated to
characterize each dimension, namely: absolute contributions
(partial contributions to inertia for each category); relative
contributions (squared cosines for each category); and the
category’s position on the axis of the dimension. For any given
dimension, the absolute contribution quantifies the importance of
each category in that dimension. By knowing that the sum of the
absolute contribution of the 61 categories in a given dimension is
1, one knows which category or categories are most important in
the dimension in question. The importance of various categories in
any given dimension explains the association among them. In our
case, values above 0.05 were deemed important. For any given
category, the relative contribution indicates its relevance to each of
the dimensions. The sum of the value obtained for such a
category’s relative contribution in the 33 dimensions is equal to 1,
thereby rendering it possible to ascertain in which dimension a
category is most relevant, with its importance being increased if it
is one of the dimensions to be explained. Lastly, a category’s
position in a dimension indicates association with categories
having the same sign, and repulsion of or inverse relation with
categories having the opposite sign.
Lastly, the category-points are plotted on different planes
formed by the main dimensions, with the above-described
statistical parameters being subsequently used to confirm or
discard visual interpretations of the data. Clinical examination of
this set of categories enables the dimension to be medically
interpreted. The number of comorbidities is used as a supple-
mentary variable in the correspondence analysis.
Ethical approval for this study was obtained from the Puerta de
Hierro University Hospital Ethics Committee for Clinical
Research (Record No. 252, dated February 22, 2010). Spain’s
1999 Personal Data Protection Act (Ley Orga ´nica de Proteccio ´n de
Datos de Cara ´cter Personal) requires that all patient registration data
be treated confidentially. The data were organizad in a database
and made available for analysis in this project and for research in
future projects. The above Ethics Committee deemed the
approach to be correct from a methodological and ethical
standpoint and, in view of the fact that electronic records were
used, waived the need for informed consent.
Results
The 129 physicians participating in the study provided care to a
registered population of 198,670 patients, mean age 43.2618.5
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years, and 94,667 men (47.6%), mean age 41.8617.3 years. In
2007, they saw a total of 149,409 patients, 75.2% of the registered
population, mean age 45.6619.6 years, made up of 84,704
women (56.6%), mean age 46.3620.0 years, and 64,705 men
(43.3%), mean age 44.7618.9 years. In all, 42% of the registered
population, 83,441 patients, mean age 54.1619.5 years, received
medical care for at least one of the 26 selected EDCs: the
breakdown showed 50,126 women (60%), mean age 54.3619.7
years, and 33,309 men (39.9%), mean age 53.8619.2 years.
Of the above population, 42% (95% CI 41.8–42.2) had at least
one chronic condition. Prevalence of multimorbidity (two or more
conditions) was 24.5% (95% CI 24.3–24.6), and was higher among
women (28.160.1) than men (19.460.1), a difference of 8.7 points
(95% CI 8.3–9.0). Prevalence increased progressively with age
until 69 years, and tended to stabilize thereafter.
The correspondence analysis enabled 98.3% of total inertia to
be explained by three dimensions, with the first accounting for
82.4%, the second 9.3% and the third the remaining 6.6%.
Figures 1 and 2 depict the relationships among the multiple
categories of the variables, the position of each on the axes of the
first and second dimensions, and the positions of these diseases in
the third vis-a `-vis the first dimension.
The first dimension showed a group of diseases (pattern A)
which, in addition to explaining a substantial part of the
information corresponding to this dimension (absolute contribu-
tion values of over 0.05), strongly represented this dimension (high
relative contribution values). On the axis of the first dimension
(Figure 1), these diseases occupied positions corresponding to
intermediate positive values, ranging from 0.71 to 1.47. This
group included cardiac arrhythmias (CAR09), hyperlipidemia
(CAR11), hypertension with and without complications
(CAR1415), and diabetes with and without complications
(END0607), diseases which, without exception, are strongly
attracted by the patient stratum aged 70 years or older.
The second group of diseases (pattern B) making up the first
dimension (Figure 1) included ischemic heart disease (CAR03),
cerebrovascular diseases (NUR05), chronic renal failure (REN01),
and congestive heart failure (CAR05), all of which are attracted by
patients over 80 years of age, and repelled by the stratum of
patients with ages under 40 years. In this second group, the
diseases on the axis of the dimension occupied positions
corresponding to high positive values, ranging from 1.75 to 2.38,
in addition to having a certain amount of inertia captured from the
first dimension, which was lower than that of the first group of
diseases but higher than 0.03. This second group of diseases
occupied positions similar to those of categories 5 and 6 or more
comorbidities than the supplementary variable, and there was thus
a strong attraction among them.
The third group of diseases (pattern C), associated with the
stratum of patients aged under 30 years and, in turn, attracted by
the category of the supplementary variable of one associated
comorbidity (Figure 1), were: asthma (ALL04); thyroid disease
(END04); anxiety or depression (PSY0109); and schizophrenia
(PSY07). This third group of diseases did not characterize the first
dimension, since its contribution to the inertia of the dimension
was limited and the values of its relative contribution were close to
zero. This group of diseases occupied negative positions on the axis
of the first dimension, similar to those of categories, ‘‘1 or more’’
and ‘‘2 or more’’ comorbidities.
Figure 1. Graphical depiction of chronic diseases, age and sex. Correspondence analysis showing the projections on the plane defined by
dimensions 1 and 2. M: Male, F: Female. mVariables most representative of dimension 2. ______ Pattern A. ---------- Pattern B. ………. Pattern C.
doi:10.1371/journal.pone.0032141.g001
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with positions similar to those of the first group of diseases and
poorly represented by the first dimension.
Table 1 shows the case-frequency distribution for each
condition at each level of comorbidity, grouped according to the
different comorbidity patterns identified in the correspondence
analysis. While some conditions, such as asthma, schizophrenia,
anxiety/depression and thyroid disease, registered a low morbidity
burden, others such as heart failure, ischemic heart disease,
cerebrovascular disease and chronic renal failure, registered a high
comorbidity burden. Finally, a larger set, comprising groups B and
C, displayed an intermediate comorbidity burden.
The second dimension (Figure 1) was made up of two sex-
related disease groups, namely, a first group that included
osteoporosis (END02) and degenerative joint disease (MUS03),
associated with the female sex, and a second group, comprising
benign prostatic hyperplasia (GUR04) and chronic obstructive
pulmonary disease (COPD) (RES04), associated with the male sex.
In addition to being well represented by the dimension, these
diseases had a high relative contribution value compared with that
for the remaining dimensions, contributing to the inertia of the
second dimension with values of over 0.05. Their positions on the
axis of the second dimension (negative or positive positions, with
extreme values in both cases) were sex-related.
The third dimension (Figure 2) explained the presence of the
following diseases in patients over the age of 80 years: congestive
heart disease (CAR05); cardiac arrhythmia (CAR09); dementia
(NUR11); and chronic ulcer (REC03). This group of diseases,
associated with the age stratum of 80 years and older, was repelled
by lipid metabolism disorders CAR 11, a disease associated with
patients aged 60 to 70 years.
Discussion
Our study shows that 42% of the population visiting the GP’s
office has at least one chronic condition, and that close on a
quarter of such subjects have two or more of these diseases. Four
comorbidity prevalence patterns were identified, namely, one
showing high, one showing low, and two showing intermediate
comorbidity rates.
Comparing our results to those of studies published to date
proves difficult, however, because the latter not only address
different index and associated diseases, but some are based on
patient-reported data, some on administrative databases, and
others on medical records.
Our study analyzed the association among 26 chronic health
conditions. As other studies, ours included diseases and risk
factors, both to facilitate comparison and by reason of their
relevance in terms of healthcare resource use.
The greatest limitation of our study lies in the data-source used.
We relied on data on the population over 14 years of age who
received medical attention at their GP’s office, using the diagnoses
shown in the EMRs to compute the number of cases. As a data-
source for morbidity studies, medical histories introduce biases
stemming from the completeness and quality of the record kept
[22]. To minimize this problem, physicians were selected who
offered the greatest assurance of quality in their records. Despite
such limitations, the prevalence of multimorbidity as estimated by
GPs’ medical records is substantially higher than that reported by
general population surveys [23], and similar to that found in
population-based longitudinal studies [24].
Another study limitation derives from the diseases selected. We
chosethosethatare frequentlyseen ingeneral practice or represent a
Figure 2. Graphical depiction of chronic diseases, age and sex. Correspondence analysis showing the projections on the plane defined by
dimensions 1 and 3. M: Male, F: Female. m Variables most representative of dimension 3. ______ Pattern A. ---------- Pattern B. ………. Pattern C.
doi:10.1371/journal.pone.0032141.g002
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the most relevant. Nonetheless, this criterion may have introduced a
bias,therebyincreasing thefrequencyof comorbidityand generating
groups that might have been different, had we included diseases that
were less frequent or registered less health service impact.
The prevalence of comorbidity is determined by the number of
associated conditions studied [23,25]. Our study, based on 26
chronic conditions, detected a crude prevalence of multimorbidity
of 24.5% in the population over 14 years of age, which was higher
in women than in men and increased with age. Comparing our
findings to those of other GP record-based studies shows that: in
Australia, Britt et al. [26], using a number of chronic conditions
similar to ours, with no age restrictions, reported a multimorbidity
rate of 29%; in The Netherlands, the authors of a study with no
restrictions on age and an open list that included acute and
chronic processes, observed a multimorbidity rate of 29.7% [25];
and in Spain, a population-based study that included a
comprehensive list of chronic diseases estimated a multimorbidity
prevalence rate of 30% [27].
Correspondence analysis is an exploratory, multivariate tech-
nique that converts a data matrix into a type of scatter plot, in
which the rows and columns are depicted as points. Though
widely known, this method is nevertheless rarely used to analyze
multimorbidity data [28]. Other research into multimorbidity
patterns has used cluster analysis to identify morbidity patterns
[17]. This type of analysis assigns each disease to only one cluster,
a rather unrealistic approach in that some diseases can be expected
to be part of more than one pattern. As a result, recent research
has turned to factor analysis [18], whereby dichotomous diagnoses
are transformed as continuous variables. Our decision to use
correspondence analysis was based on the fact that it is really a
principal components analysis of categorical data and is a
multivariate method which enables one to obtain an overall idea
of the data and the interrelationships among the various diseases.
The chronically ill patients in our study registered four patterns of
comorbidity but, in every instance, over half the cases were
associated with at least one other chronic condition. Other studies
have also established different comorbidity profiles by reference to
Table 1. Comorbidity associated with chronic diseases.
EDC No. Cases ID only
ID+1o r
more
ID+2o r
more
ID+3o r
more
ID+4o r
more
ID+5o r
more
PATTERN A
Hypertension (with and without complications) [CAR1415] 28760 11.05 88.95 67.95 44.05 24.45 12.10
Disorders of lipid metabolism [CAR11] 22345 13.19 86.81 65.76 43.29 24.58 12.49
Type 2 diabetes (with and without complications) [END0607] 10058 9.67 90.33 74.55 54.11 33.86 18.86
Cardiac arrhythmia [CAR09] 5777 8.60 91.40 78.43 61.28 42.08 25.36
PATTERN B
Cerebrovascular disease [NUR05] 2658 5.91 94.09 83.07 66.59 46.46 28.33
Ischemic heart disease (excluding AMI) [CAR03] 2344 3.97 96.03 86.90 70.56 49.40 32.81
Chronic renal failure [REN01] 1964 5.86 94.14 84.57 69.25 51.12 33.50
Congestive heart failure [CAR05] 1377 3.05 96.95 90.12 78.29 61.26 42.19
PATTERN C
Anxiety and depression [PSY0109] 27357 36.46 63.54 39.54 24.38 13.91 7.14
Thyroid disease [END04] 19299 31.97 68.03 42.49 26.26 15.12 7.86
Asthma [ALL04] 7614 40.74 59.26 34.98 21.55 13.12 7.17
Schizophrenia and affective psychoses [PSY07] 1309 31.02 68.98 44.16 24.68 13.67 7.87
PATTERN D
Obesity [NUT03] 19640 17.11 82.89 60.58 39.76 22.68 11.36
Osteoporosis [END02] 6143 9.56 90.44 72.54 49.44 29.01 14.76
Deafness, hearing loss [EAR08] 5403 18.88 81.12 61.08 42.88 27.63 15.57
Malignant neoplasms [NEOMAL] 5138 14.25 85.75 66.62 46.44 28.67 15.84
Degenerative joint disease [MUS03] 4452 11.25 88.75 72.24 52.34 32.79 17.65
Benign prostatic hypertrophy [GUR04] 4089 11.49 88.51 68.38 45.98 27.42 14.97
Emphysema, chronic bronchitis, COPD [RES04] 3183 9.80 90.20 72.86 54.16 35.38 21.08
Generalized atherosclerosis [CAR10] 2705 13.20 86.80 72.16 55.75 39.26 23.51
Glaucoma [EYE08] 2450 7.31 92.69 79.47 60.98 40.49 23.80
Chronic liver disease [GAS05] 2121 13.11 86.89 67.61 48.33 32.81 18.39
Dementia and delusions [NUR11] 1112 11.33 88.67 73.38 52.25 33.45 19.06
Chronic skin ulcer [REC03] 955 8.90 91.10 77.49 58.95 41.05 24.91
Cardiac valve disease [CAR06] 936 7.69 92.31 82.16 64.10 47.54 30.02
Parkinson’s disease [NUR06] 805 9.57 90.43 77.14 55.53 38.63 26.09
EDC: expanded diagnosis cluster; ID: index disease; COPD: chronic obstructive pulmonary disease; AMI: acute myocardial infarction.
doi:10.1371/journal.pone.0032141.t001
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comorbidity in patients with heart and cerebrovascular diseases,
and a lower rate in patients with asthma and mental disorders. A
recent study addressing chronic respiratory diseases [30] reported
different patterns for asthma and COPD. In an earlier study on
heart failure, we found that these patients have a very high
comorbidity burden [31].
Based on the chronic diseases chosen, comorbidity was the rule
in our study, and only one small chronic disease group (pattern C)
displayed a low comorbidity burden. In such circumstances, health
service coordination and integration becomes a necessity. Disease
management programs, targeting a specific illness, have limited
application in the care of chronic patients and are restricted to
those included in the low comorbidity pattern. Case management
programs would appear to offer a more logical alternative, with
GPs, by virtue of their involvement in the care of the index disease
and other conditions, having to assume a pivotal role as case
managers in respect of such patients [29].
Comorbidity has an impact on health outcomes [32]. Although
clinical research stresses the internal validity of clinical trials,
aspects linked to external validity tend to be overlooked.
Consequently, the feasibility of extrapolating the research findings
to clinical practice is limited [33,34]. Clinical decisions should take
relevant clinical trials into account, and studies that produce
results which are applicable to routine clinical practice are relevant
[35]. All in all, relevance depends on external validity, and in this
respect, comorbidity is a key factor which is, nevertheless, only
taken into account in clinical trials for the purpose of excluding
patients affected by it.
Furthermore, clinical practice guidelines and disease manage-
ment programs usually focus on specific diseases and fail to take
the presence of comorbidity into consideration. In the light of our
results, there is a small group of chronic conditions (pattern C)
which tend to be isolated entities. The majority of the chronic
conditions are, however, associated with one another. This is
especially true of one group (pattern B), in which it is interesting to
note that the diseases involved very rarely develop as isolated
entities and are most frequently associated with a high comorbidity
rate. In such cases, the application of the results of research studies
is questionable, and there is thus a clear need for new clinical
practice guidelines which take into account the comorbidity of
patients presenting with any disease in this group.
Comorbidity limits the capacity for self-care [36]. Integrated
care for the problems of the chronically ill patient with
comorbidity improves overall outcomes and adherence to
treatment [37], and continuity serves to reduce healthcare costs
[38]. In such a context, a longitudinal, generalist approach may be
the most suitable strategy [39] and, given their generalist training,
family physicians need to play a central role in both the care and
coordination of care of chronically ill patients.
In conclusion, the correspondence analysis enabled us to
identify four comorbidity patterns that grouped diseases as follows:
one showing diseases with a high comorbidity burden; one
showing diseases with a low comorbidity burden; and two showing
diseases with an intermediate comorbidity burden.
Identification of these comorbidity patterns in patients with
chronic diseases gives rise to new questions, such as: is the same
healthcare model valid for all four groups?; once a given disease has
been identified, could the diagnosis of another in the same group be
envisaged?; why do only some and not all diseases tend to occur in
association with others?; and, what characteristics or risk factors are
shared by diseases which tend to occur in association with others?
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